Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease

• Main Authors: Antonio Vitale (Author), Virginia Berlengiero (Author), Jurgen Sota (Author), Luisa Ciarcia (Author), Nicola Ricco (Author), Sara Barneschi (Author), Mariam Mourabi (Author), Giuseppe Lopalco (Author), Chiara Marzo (Author), Francesca Bellisai (Author), Florenzo Iannone (Author), Bruno Frediani (Author), Luca Cantarini (Author)
• Format: Book
• Published: Hindawi Limited, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Interleukin-1 inhibition has revealed to be a successful treatment approach for patients with adult-onset Still's disease (AOSD). However, real-life experience is focused on the use of anakinra, while data about canakinumab (CAN) are mainly based on case reports and small case serie...